🔎 Trials Near Me

Dachaigh › Leukemia myeloid geur › Colorado › Denver

Sgrùdaidhean clionaigeach Leukemia myeloid geur ann an Denver, CO

Tha 12 sgrùdaidhean airson Leukemia myeloid geur a’ lorg phàirtichean aig làraichean ann agus timcheall air Denver (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • AdventHealth Porter, Denver
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

A’ fastadhÌre 3
  • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
6 Months – 21 Years · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT04293562

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

A’ fastadhÌre 3
  • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
Aoisean 1 gu 25 · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07022678

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

A’ fastadhÌre 1
  • Colorado Blood Cancer Institute, Denver
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT06834282

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

A’ fastadhÌre 1/2
  • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
Suas gu aois 22 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04726241

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

A’ fastadhÌre 3
  • Colorado Blood Cancer Institute, Denver
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

A’ fastadhÌre 1
  • Colorado Blood Cancer Institute, Denver
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT06001788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

A’ fastadhSgrùdadh amharc
  • Presbyterian St. Luke's/Colorado Blood Cancer Institute, Denver
Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

A’ fastadhÌre 1/2
  • Colorado Blood Cancer Institute, Denver
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 24 Màrt 2026 · NCT04988555

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

A’ fastadhÌre 1
  • Colorado Blood Cancer Institute, Denver
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Màrt 2026 · NCT05735184

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

A’ fastadhFàilte do shaor-thoilich fhallain
  • University of Colorado Denver I Anschutz Medical Campus, Denver
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 25 Iuch 2025 · NCT05237258

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

A’ fastadhÌre 1
  • Colorado Blood Cancer Institute, Denver
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Cèit 2025 · NCT06634394

Sgrùdaidhean Leukemia myeloid geur ann am bailtean eile

Sgrùdaidhean eile ann an Denver

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.